SAN FRANCISCO, May 13, 2020 /PRNewswire/ -- Globant (NYSE:
GLOB), a digitally-native technology services company, today
announced the launch of its Life Sciences Studio. The new studio
brings together Globant's biological and technological expertise to
help healthcare, agriculture and pharmaceutical organizations
become digitally-enabled to face the new world. Our ultimate goal
is to make people's lives healthier, society more equal and the
Earth more sustainable.
Globant's Life Sciences Studio is committed to digitizing
biomedical journeys by bringing together different specialists:
bioinformatics engineers, mathematicians, biologists, platform
experts and data scientists – world-class bio-sciences talent who
work together to deliver technical state-of-the-art solutions.
"At Globant, we're committed to helping organizations use our
deep technology knowledge to enhance issues that are core to
humanity, such as the use of genomic information for personalized
treatments and disease prevention, better and more accessible
medicine generation and more efficient and nourishing food
production," said Kevin Janzen,
Managing Director and Life Sciences Studio Partner. "The current
COVID-19 crisis is forcing organizations to rethink the way they
approach healthcare, pharma and agriculture, and we're proud to
help them design and develop innovative solutions that are helping
them navigate the current landscape."
The Life Sciences Studio will provide offerings and expertise in
the following areas, among others:
- Smart farming – The studio helps its clients get the
most out of their food production by using a variety of tools,
theories and technologies to feed the increasing demand from the
population.
- Image diagnosis – Globant helps clients navigate
the complex biomedicine field by helping medical professionals
accelerate the time patients' diseases can be found, diagnosed and
treated.
- Healthcare interoperability – With its Life Sciences
Studio, Globant is focused on digitizing healthcare ecosystems
developing custom solutions for its customers in the healthcare
industry.
- Telemedicine and medical digital tech – At a time
where telemedicine has never been more important, Globant helps
medical companies bridge the gap on the dynamics of diagnosis and
inter-patient communications.
- Precision Medicine – Globant addresses the
increasing need for new techniques, methods and tools to enable the
use of medicine tailored for specific circumstances – including
genetic screening, drug development as well as personalized disease
detection, treatment and evolution.
By introducing its Life Sciences Studio, Globant demonstrates
further commitment to its Be Kind initiative – a sustainability
program that aims to make the world a better place. Globant's Life
Sciences studio recently collaborated with the Integrated Breeding
Platform (IBP) to help fight global hunger by digitizing plant
breeding.
To learn more about Globant's Life Sciences studio, visit:
https://www.globant.com/studio/life-sciences.
About Globant
We are a digitally-native company where
innovation, design and engineering meet scale. We use the latest
technologies in the digital and cognitive fields to transform
organizations in every aspect.
- We are more than 11,800 professionals and we are present in 17
countries working for companies like Google, Rockwell Automation,
Electronic Arts and Santander, among others.
- We are featured as a business case study at Harvard, MIT and
Stanford.
- We are a member of the Cybersecurity Tech Accord (2019)
For more information, visit www.globant.com
Media Contact:
Kellie Flaherty
Kellie.flaherty@walkersands.com
773-459-6954
View original content to download
multimedia:http://www.prnewswire.com/news-releases/globant-launches-new-life-sciences-studio-301058706.html
SOURCE Globant